BioTech 365

JANUARY 11, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bluebird to spin off cancer therapies into new company.Bluebird to spin off cancer therapies into new company ntaylor Mon, 01/11/2021 – 08:21 from FierceBiotech: Biotech [link].

Research 40

Research 40

BioTech 365

APRIL 8, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bannister joins SVB to help companies raise cash, access public markets.Bannister joins SVB to help companies raise cash, access public markets ntaylor Thu, 04/08/2021 – 08:17 from … Continue reading →

Marketing 40

Marketing Research 40

STAT News

NOVEMBER 16, 2022

Amid a bumpy few years for development in Boston, the business of building lab space has been a gleaming bright spot, with billions upon billions of dollars pouring in to house the region’s booming life science industry. Now, though, even the lab boom is slowing amid a rocky economy, rising interest rates, and soaring construction costs.

Life Science 105

Life Science Development 105

BioTech 365

MARCH 19, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: How Five Prime suitor Amgen battled multiple companies for its biotech, and won.How Five Prime suitor Amgen battled multiple companies for its biotech, and won badams Fri, … Continue reading →

Research 40

Research 40

BioTech 365

JUNE 4, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Organon launches ready to shop for women’s health companies in biotech, medtech and more.Organon launches ready to shop for women’s health companies in biotech, medtech and more … Continue reading →

Research 40

Research 40

Fierce Pharma

DECEMBER 13, 2023

Using Tuesday to announce good news—that its $43 billion acquisition of Seagen would be | Using Tuesday to announce good news—that its $43 billion acquisition of Seagen would be finalized on Thursday—Pfizer sandwiched its bad news, which came on Wednesday with its 2024 guidance. The company expects revenue to reach between $58.5

Production 143

Production Sales 143

BioTech 365

OCTOBER 28, 2020

DUBLIN–(BUSINESS WIRE)–The “Privately-owned Companies – COVID-19 Progress Daily” report has been added to ResearchAndMarkets.com’s offering.

40

40

Pharma Business Blog

APRIL 8, 2020

Even though there has been no news about the development in the EU-Swiss negotiations, which could secure specific status of the Swiss manufacturers, due to the COVID 19 outbreak the Commission announced on 25 March 2020 that it works on a proposal to postpone the application date of the Medical Devices Regulation (MDR) for one year.

Manufacturing 52

Manufacturing Regulation Development Marketing 52

Bio Pharma Dive

MAY 27, 2021

Safety monitors cleared the company to test a higher dose after reviewing data from 10 patients, providing some hopeful news after recent setbacks for experimental drugs targeting the genetic disease.

Gene Therapy 304

Gene Therapy Genetic Disease Gene Genetics 304

BioTech 365

DECEMBER 29, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca taps Ionis to join crowd of companies gunning for rare heart disease in deal worth billions in biobucks.AstraZeneca taps Ionis to join crowd of companies gunning … Continue reading →

Research 40

Research 40

BioTech 365

APRIL 12, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Vaccitech, the company that developed the AstraZeneca COVID-19 shot, files for a Nasdaq IPO.Vaccitech, the company that developed the AstraZeneca COVID-19 shot, files for a Nasdaq IPO … Continue reading →

Development 40

Development Research 40

Pharma Business Blog

JULY 2, 2021

German pharmaceutical wholesalers are only allowed to purchase drugs from companies holding an appropriate authorization granted in one of the EU Member States. • Der Beitrag WEBINAR – Pharma news: German court decision – Sale of drugs from a Swiss company and new EU requirements erschien zuerst auf Pharmabusinessblog.

Sales 52

Sales Drugs Licensing Licensing 52

Pharmaceutical Technology

JUNE 28, 2023

Shares in Centogene rose by 41% following news of the collaboration with the Saudi government-backed biopharma company.

Genetics 162

Genetics 162

BioTech 365

MARCH 16, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: GSK, German Merck’s $4.2B bintrafusp alfa drug flops again, but companies squint to see glimmers of hope.GSK, German Merck’s $4.2B

Drugs 40

Drugs Research 40

BioTech 365

OCTOBER 30, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bellicum shares nose-dive on poor CAR-T data, program pause—company axes 79% of staffers.Bellicum shares nose-dive on poor CAR-T data, program pause—company axes 79% of staffers badams Fri, … Continue reading →

Research 40

Research 40

Fierce Pharma

JANUARY 8, 2024

It took Bristol Myers Squibb’s new CEO Chris Boerner 16 minutes into his 24-minute presentation to address the big news the company made last month, with its holiday

120

120

Pharma Times

SEPTEMBER 8, 2023

Clinically significant results have emerged from trial evaluating the company’s AMO-02 candidate - News - PharmaTimes

Trials 143

Trials 143

Pharma Times

SEPTEMBER 8, 2023

The company will use its AI technology during a sub-study to analyse the effect of lansoprazole - News - PharmaTimes

Trials 151

Trials 151

Pharma Times

NOVEMBER 23, 2023

Both companies will use their platforms to accelerate drug discovery and development - News - PharmaTimes

Research 131

Research Development Drugs 131

Pharma Times

OCTOBER 25, 2023

The company will launch a clinical investigation of EA-2351 for geographic atrophy - News - PharmaTimes

139

139

pharmaphorum

FEBRUARY 6, 2024

Stay updated with the latest news on hiring trends in the pharmaceutical and biotech industries. Learn about the companies and professionals making waves in the field from January 2024 in a new instalment of Changing Faces.

110

110

Pharma Times

OCTOBER 4, 2023

The companies aim to bring gene therapies to patients sooner than traditional approaches - News - PharmaTimes

Gene Therapy 135

Gene Therapy Gene 135

Pharma Times

SEPTEMBER 11, 2023

Both companies will work to advance the development of novel radiopharmaceuticals - News - PharmaTimes

Development 139

Development 139

Pharma Times

OCTOBER 5, 2023

It will be the company’s first platform to be installed in an external scientific setting - News - PharmaTimes

DNA 130

DNA Development 130

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. At the moment, biotech C-suite executives agree that the bear market may impact more companies in the future. In this sense, companies must exercise caution in how they carry on.

Marketing 324

Marketing Gene Therapy Manufacturing Pharma Companies 324

Pharma Times

OCTOBER 9, 2023

The agreement builds on the companies’s existing partnership - News - PharmaTimes

Research 130

Research 130

BioSpace

NOVEMBER 28, 2023

After Verve Therapeutics recently announced gene editing therapy results, the company is offering up its stock to the public and Eli Lilly. However, the stock was down 13% Wednesday on the news.

Gene Editing 111

Gene Editing Gene 111

Pharmaceutical Technology

FEBRUARY 2, 2023

Artificial intelligence (AI) continues to be in the news, and as pharma companies invest more to make sure they’re ahead of the game, international agencies have also started to catch up with regulations for AI-led healthcare research. You can also subscribe here to receive email notifications when a new issue is available.

Gene Therapy 246

Gene Therapy Gene Pharma Companies Clinical Trials 246

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. At the moment, biotech C-suite executives agree that the bear market may impact more companies in the future. In this sense, companies must exercise caution in how they carry on.

Marketing 162

Marketing Gene Therapy Manufacturing Pharma Companies 162

Pharma Times

JUNE 16, 2023

Company will gain access to a considerable pipeline of liquid products covering various disease areas - News - PharmaTimes

Production 117

Production 117

Pharma Times

JULY 12, 2023

Company adds a number of additional brands from Sanofi following initial take overs in 2021 - News - PharmaTimes

Branding 116

Branding 116

Pharma Times

JULY 18, 2023

Company’s phase 3 research showed the importance of running biomarker-powered clinical trials - News - PharmaTimes

Clinical Trials 108

Clinical Trials Clinical Trials Trials Research 108

Pharma Times

JULY 25, 2023

The company will utilise Qureight’s AI technology to undergo studies across a variety of complex lung diseases - News - PharmaTimes

Research 104

Research 104

Pharma Times

JULY 31, 2023

The phase 2 study involves company’s eftilagimod alpha therapy - News - PharmaTimes

Trials 116

Trials 116

Pharma Times

JUNE 16, 2023

DEVOTE grant will allow acute care patient access and a supporting infrastructure for the company - News - PharmaTimes

113

113

Fierce Pharma

JUNE 20, 2023

AstraZeneca, the largest multinational pharma company in China, has reportedly made plans to separate its local business there in case geopolitical tensions worsen. | The largest multinational pharma company in China has reportedly made plans to separate its local business in case geopolitical tensions worsen.

Pharma Companies 104

Pharma Companies 104

Pharma Times

JULY 13, 2023

Results are from company’s phase 2 head and neck cancer trial with lead NOX inhibitor candidate - News - PharmaTimes

Trials 109

Trials 109